Home » Immunomedics Reports Results of Lymphoma Therapy With Veltuzumab
Immunomedics Reports Results of Lymphoma Therapy With Veltuzumab
Immunomedics, Inc., … Tuesday announced that subcutaneous injections of low doses of veltuzumab in patients with non-Hodgkin’s lymphoma (NHL)
achieved sustained serum levels of pharmacologically active antibody, with objective response rates comparable to those seen with higher intravenous doses.
CNNMoney
CNNMoney
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May